Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. is an enterprise in Ecuador, with the main office in Guayaquil. It operates in the Psychiatric and Substance Abuse Hospitals industry. It was incorporated on January 25, 2018. There are currently 4 (2024) people employed by Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A.. The latest financial highlights indicate a net sales revenue drop of 33.29% in 2025. Over the same period, its total assets grew by 19.14%. In 2025, Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A.’s net profit margin increased by 4.79%.

Headquarters
Km. 13 Via Puntilla-Salitre, 5-6
Guayaquil; Guayas;

Contact Details: Purchase the Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. report to view the information.

Basic Information

Total Employees:

Purchase the Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. report to view the information.

Registered Capital:

Purchase the Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. report to view the information.

Financial Auditors:

Purchase the Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. report to view the information.

Incorporation Date:

January 25, 2018

Key Executives

Purchase this report to view the information.

President

Purchase this report to view the information.

General Manager

Ownership Details

Purchase this report to view the information.

50%

Purchase this report to view the information.

50%

Company Performance

Financial values in the chart are available after Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. report is purchased.

Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service

Key Financial Highlights

Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.

Net sales revenue

-33.29%▼

Total Operating Revenue

-33.29%▼

Operating Profit

-42.69%▼

EBITDA

-17.24%▼

Net Profit/Loss for the Period

10.51%▲

Total Assets

19.14%▲

Total Equity

4.62%▲

Operating Profit Margin

-2.25%▼

Net Profit Margin

4.79%▲

Return on Equity (ROE)

0.23%▲

Debt / Equity

8.47%▲

Quick Ratio

-0.36%▼

Cash Ratio

0.2%▲

Hemodinamia e Intervencionismo Endovascular Zelaya & Cabral S.A. (Ecuador)